Author

Flore Nardella

Centre National de la Recherche ScientifiqueORCID 0000-0002-3811-1633Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:plant (other)· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Armin PasseckeriD· 1 shared Artur ScherfiD· 1 shared Basil T. ThommeniD· 1 shared Benjamin BlascoiD· 1 shared Christin GumppiD· 1 shared Dennis GómeziD· 1 shared Didier LeroyiD· 1 shared Françoise Benoit‐VicaliD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Armin PasseckerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintJan 7, 2026

Selective Disruption of Plasmodium falciparum mitochondrial DNA via G-Quadruplex-Binding Ligand RHPS4 Provides a Novel Antimalarial Strategy

Mariam Salim, Lucie Paloque, Thibaud Reyser…·Dennis Gómez

This study shows RHPS4, a G-quadruplex ligand, disrupts Plasmodium falciparum mitochondrial DNA and metabolism, offering a new antimalarial strategy by targeting mtDNA G4 structures.

1 citation

plant (other)experimental assay

𝕏 PostBluesky

MicrobiologyNature CommunicationsPeer-reviewedJul 25, 2025

An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs

Nicolas M. B. Brancucci, Christin Gumpp, Geert‐Jan van Gemert…·Till Steffen Voss

The paper develops an in vitro and in vivo platform for testing malaria transmission-blocking drugs using engineered Plasmodium falciparum gametocytes and humanized mice.

8 citationstop 3%

humanmouse

𝕏 PostBluesky